EAM
GEVA

Eagle Asset Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Eagle Asset Management’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-371,816
Closed -$36.3M – 695
2015
Q1 		$36.3M Buy
371,816
+239,471
+181% +$25.4M 0.21% 160
2014
Q4 		$12.3M Sell
132,345
-2,050
-2% -$162K 0.07% 300
2014
Q3 		$9.24M Buy
+134,395
New +$9.62M 0.05% 334

Eagle Asset Management's GEVA Position: Q2 2015 in Review

Eagle Asset Management sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 371,816 shares — an estimated $36.3M sold.

Eagle Asset Management first reported a position in GEVA in Q3 2014 and held it in 3 quarters. The position peaked at $36.3M in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Eagle Asset Management reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Eagle Asset Management sold 371,816 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $36.3M.
  • Eagle Asset Management first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q3 2014 and held it in 3 quarters.
  • Eagle Asset Management's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $36.3M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Eagle Asset Management's 13F filing for Q2 2015, filed 15 Jul 2015.